2C4, a monoclonal antibody against HER2, disrupts the HER kinase signaling pathway and inhibits ovarian carcinoma cell growth-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

2C4, a monoclonal antibody against HER2, disrupts the HER kinase signaling pathway and inhibits ovarian carcinoma cell growth

Published:2005-11-01 Issue:12 Volume:104 Page:2701-2708
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Takai Noriyuki,Jain Anjali,Kawamata Norihiko,Popoviciu Laura M.,Said Jonathan W.,Whittaker Sadie,Miyakawa Isao,Agus David B.,Koeffler H. Phillip

Funder

National Institutes of Health (NIH)

S. and A. Schwartz Family

Marie and David Green Fund

Women's Cancer Research Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference25 articles.

1. Untangling the ErbB signaling network;Yarden;Nat Rev Mol Cell Biol.,2001

2. The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions;Alroy;FEBS Lett.,1997

3. Epidermal growth factor-related peptides and their receptors in human malignancies;Salomon;Crit Rev Oncol Hematol.,1995

4. A Neu acquaintance for ErbB3 and ErbB4: a role for receptor heterodimerization in growth signaling;Carraway;Cell.,1994

5. ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms;Tzahar;J Biol Chem.,1994

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Tyrosine Kinases in Ovarian Cancer: Small Molecule Inhibitor and Monoclonal Antibody, Where Are We Now?;Biomedicines;2022-08-29

2. Trastuzumab/pertuzumab combination therapy stimulates antitumor responses through complement-dependent cytotoxicity and phagocytosis;JCI Insight;2022-03-22

3. Monoclonal Antibodies, Small Molecule Inhibitors and Antibody-drug Conjugates as HER2 Inhibitors;Current Medicinal Chemistry;2021-06-08

4. Improving Receptor-Mediated Intracellular Access and Accumulation of Antibody Therapeutics—The Tale of HER2;Antibodies;2020-07-13

5. Structural insight into a matured humanized monoclonal antibody HuA21 against HER2-overexpressing cancer cells;Acta Crystallographica Section D Structural Biology;2019-05-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3